Art

J-GLOBAL ID：202002213720769485   Reference number：20A0765243

A Qualitative Study on the Differences Between Trial Populations and the Approved Therapeutic Indications of Antineoplastic Agents by 3 Regulatory Agencies From 2010 to 2018

2010年から2018年までの3つの調節機関による抗腫瘍薬の試験集団と承認された治療適応の間の差異に関する定性的研究【JST・京大機械翻訳】

Author (6)： Sumi Eriko (Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan) ,  Asada Ryuta (Innovative and Clinical Research Promotion Center, Graduate School of Medicine, Gifu University, Gifu, Japan) ,  Lu Ying (Department of Biomedical Data Science, Stanford University, Stanford, CA, USA) ,  Ito-Ihara Toshiko (The Clinical and Translational Research Center, University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Grimes Kevin V. (Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA) ,  Grimes Kevin V. (SPARK Translational Research Program, Stanford University School of Medicine, Stanford, CA, USA)
Material： Clinical Therapeutics  (Clin Ther)
Volume： 42  Issue： 2  Page： 305-320.e0  Publication year： 2020 
JST Material Number： A1157A  ISSN： 0149-2918  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： The present study aimed to exa...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0765243&from=J-GLOBAL&jstjournalNo=A1157A") }}

Thesaurus term： biomarker ,  stratification ,  Europe ,  combination therapy ,  *antitumor drug ,  Food and Drug Administration ,  clinical trial ,  Research Subjects
Semi thesaurus term： 臨床試験プロトコル ,  *治療適応 , 【Automatic Indexing@JST】

Author keywords (5)： anticancer drugs ,  biomarker ,  regulatory agency ,  therapeutic indications ,  trial population

JST classification (3)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Immunotherapy for tumors  (GE03035B) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Terms in the title (8)： 調節 ,  抗腫瘍薬 ,  試験 ,  集団 ,  承認 ,  治療適応 ,  差異 ,  研究